Long-term safety study of azetukalner for bipolar depression
Treatments studied
Part of Mental health clinical trials.
This study is looking at the long-term safety of azetukalner for people with bipolar I or II depression who have already completed a previous trial of this drug. It is an open-label study, meaning everyone will receive the active medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have completed a full treatment period in a previous study testing azetukalner for bipolar depression.
- You must be willing to use effective birth control if you or your partner can become pregnant.
- You cannot be pregnant, breastfeeding, or planning to become pregnant.
- You cannot have any medical condition or ongoing side effect that would make the study unsafe for you.
- You cannot be at significant risk of self-harm or suicidal behavior.
- You cannot be planning to join another experimental drug or device trial during this study or within 28 days after it ends.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the study drug azetukalner can help reduce depression symptoms in people with bipolar I or II disorder who are currently having a depressive episode. You would be randomly assigned to receive either the drug or a placebo (inactive pill) to see which works better.
This study checks how safe a kid’s ongoing treatment is over a longer period. It is mainly for children who already finished a related study and may benefit from continuing the same medicines.
This Phase 3 study tests a stronger medication approach after your first current treatment hasn’t worked well enough. It targets people with schizophrenia, major depressive disorder, or bipolar depression who still have significant symptoms and life impact.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This Phase 2 study tests a medication that works on NMDA receptors to improve depression symptoms in people with bipolar I disorder. It may help if you’re currently in a bipolar depression episode and other mood treatments haven’t fully controlled it.
This study looks at how well patients with bipolar disorder do while taking the medication olanzapine. You will continue your regular treatment, and answer questions about your experience.
Hear when a new Bipolar Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.